<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:112.4pt;left:447.3pt;line-height:6.0pt"><span style="font-family:GillSansMTPro,serif;font-size:6.0pt;color:#ffffff">https://doi.org/10.1177/1545968320962508</span></p>
<p style="top:60.7pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">Neurorehabilitation and</span></p>
<p style="top:69.2pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">Neural Repair</span></p>
<p style="top:77.7pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">2020, Vol. 34(11) 979 &#x2013;985</span></p>
<p style="top:86.2pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">&#xa9; The Author(s) 2020</span></p>
<p style="top:94.7pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">Article reuse guidelines: </span></p>
<p style="top:103.2pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">sagepub.com/journals-permissions</span></p>
<p style="top:111.7pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">DOI: 10.1177/1545968320962508</span></p>
<p style="top:120.2pt;left:447.3pt;line-height:7.0pt"><span style="font-family:GillSansMTPro,serif;font-size:7.0pt">journals.sagepub.com/home/nnr</span></p>
<img style="position:absolute;transform:matrix(.32,0,-0,.32,443,-18.733235)" src="data:image/jpeg;base64,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">
<p style="top:38.8pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Review Article</span></i></p>
<p style="top:521.1pt;left:63.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Introduction</span></b></p>
<p style="top:540.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">A staggering 1 out of every 16 Americans suffer from periph-</span></p>
<p style="top:552.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eral nerve injury (PNI).</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">1</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Most of these individuals are young </span></p>
<p style="top:564.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">adults who experienced a traumatic upper limb injury.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">2</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:576.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Severe PNI leads to functional disability and has a disastrous </span></p>
<p style="top:588.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">effect on a person&#x2019;s quality of life.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">3</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Functional recovery after </span></p>
<p style="top:600.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">PNI is influenced by both the location and severity (classifi-</span></p>
<p style="top:612.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cation) of the lesion. Improved functional outcomes are seen </span></p>
<p style="top:624.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in distal PNIs compared with proximal due to decreased tar-</span></p>
<p style="top:636.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">get reinnervation distance.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">4,5</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Neurosurgical guidelines advo-</span></p>
<p style="top:648.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cate early diagnosis of PNI after trauma is critical for </span></p>
<p style="top:660.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">achieving the best possible outcomes,</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> while timeline for </span></p>
<p style="top:672.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration and repair (if needed) is dependent on the </span></p>
<p style="top:684.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">extent of damage to specific structures within the nerve </span></p>
<p style="top:696.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">itself.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6,7</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Comprehension of PNI etiologies and treatment </span></p>
<p style="top:708.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">standards is necessary to properly analyze potential strate-</span></p>
<p style="top:720.7pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">gies for enhancing peripheral nerve regeneration.</span></p>
<p style="top:521.1pt;left:318.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Materials and Methods</span></b></p>
<p style="top:540.7pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">A systematic search was performed on PubMed, IEEE, and </span></p>
<p style="top:552.7pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Web of Science databases from database creation to </span></p>
<p style="top:564.7pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">February 2020. PubMed, Ovid, and Cochrane databases </span></p>
<p style="top:576.7pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">were queried using the following keywords: (&#x201c;electrical&#x201d; or </span></p>
<p style="top:2.0pt;left:8.4pt;line-height:9.5pt"><b><span style="font-family:Times New Roman,serif;font-size:9.5pt;color:#ffffff">962508</span></b><span style="font-family:GillSansMTPro,serif;font-size:1.0pt;color:#ffffff"> NNR</span><span style="font-family:Times New Roman,serif;font-size:1.0pt;color:#ffffff">XXX10.1177/1545968320962508Neurorehabilitation and Neural Repair</span><b><span style="font-family:GillSansMTPro,serif;font-size:1.0pt;color:#ffffff">Ransom et al</span></b></p>
<p style="top:9.8pt;left:8.4pt;line-height:1.0pt"><i><span style="font-family:Times New Roman,serif;font-size:1.0pt;color:#ffffff">review-article</span></i><span style="font-family:Times New Roman,serif;font-size:1.0pt;color:#ffffff">2020</span></p>
<p style="top:605.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">1</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">University of Arkansas for Medical Sciences, Little Rock, AR, USA</span></p>
<p style="top:615.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">2</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">California Institute of Technology, Pasadena, CA, USA</span></p>
<p style="top:625.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">3</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Keck School of Medicine of USC, Los Angeles, CA, USA</span></p>
<p style="top:635.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">4</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">University of California, Irvine, Irvine, CA, USA</span></p>
<p style="top:645.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">5</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Geisinger Health System, Danville, PA, USA</span></p>
<p style="top:655.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">6</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">University of Pittsburgh, Pittsburgh, PA, USA</span></p>
<p style="top:665.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">7</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Mayo Clinic Alix School of Medicine, Rochester, MN, USA</span></p>
<p style="top:675.2pt;left:318.0pt;line-height:5.2pt"><span style="font-family:GillSansMTPro,serif;font-size:5.2pt">8</span><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">University of California, San Diego, La Jolla, CA, USA</span></p>
<p style="top:691.8pt;left:318.0pt;line-height:8.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Corresponding Author:</span></b></p>
<p style="top:701.8pt;left:318.0pt;line-height:8.0pt"><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Ronald Sahyouni, Department of Neurological Surgery, University of </span></p>
<p style="top:711.8pt;left:318.0pt;line-height:8.0pt"><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">California, San Diego, 9500 Gilman Dr La Jolla, CA 92093, USA.</span></p>
<p style="top:721.8pt;left:318.0pt;line-height:8.0pt"><span style="font-family:GillSansMTPro,serif;font-size:8.0pt">Email: sahyouniron@gmail.com</span></p>
<p style="top:69.9pt;left:63.0pt;line-height:18.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:18.0pt">Translational Approaches to  </span></b></p>
<p style="top:89.9pt;left:63.0pt;line-height:18.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:18.0pt">Electrical Stimulation for  </span></b></p>
<p style="top:109.9pt;left:63.0pt;line-height:18.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:18.0pt">Peripheral Nerve Regeneration</span></b></p>
<p style="top:164.7pt;left:63.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Seth C. Ransom</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">1</span></b></sup></p>
<p style="top:164.7pt;left:169.6pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">, Shane Shahrestani, MS</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">2,3</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">,  </span></b></p>
<p style="top:178.7pt;left:63.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Brian V. Lien, MS</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">4</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">, Ali R. Tafreshi, MD</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">5</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">, Nolan J. Brown</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">4</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">,  </span></b></p>
<p style="top:192.7pt;left:63.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Brian Hanst, MS</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">4</span></b></sup></p>
<p style="top:192.7pt;left:170.9pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">, Brandon M. Lehrich</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">6</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">, R. Chase Ransom, MD, PhD</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">7</span></b></sup><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">,  </span></b></p>
<p style="top:206.7pt;left:63.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">and Ronald Sahyouni, MS, MD, PhD</span></b><sup><b><span style="font-family:GillSansMTPro,serif;font-size:7.8pt">8,</span></b></sup></p>
<p style="top:256.3pt;left:63.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Abstract</span></b></p>
<p style="top:268.3pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Background.</span></i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt"> Achieving functional repair after peripheral nerve injury (PNI) remains problematic despite considerable advances </span></p>
<p style="top:280.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">in surgical technique. Therein, questions lie regarding the variable capacity of peripheral nerves to regenerate based on </span></p>
<p style="top:292.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">environmental influence. In-depth analyses of multiple therapeutic strategies have ensued to overcome these natural obstacles. </span></p>
<p style="top:304.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Of these candidate therapies, electrical stimulation has emerged a frontrunner. Extensive animal studies have reported the </span></p>
<p style="top:316.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">ability of brief intraoperative electrical stimulation (BES) to enhance functional regeneration after PNI. Despite these reports, </span></p>
<p style="top:328.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">the exact mechanisms by which BES enhances regeneration and its effects on long nerve lesions are largely unknown. Indeed, </span></p>
<p style="top:340.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">clinical translation of this seemingly simple therapeutic has not been so simple, but a few studies performed in humans have </span></p>
<p style="top:352.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">yielded highly encouraging results. </span><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Objective.</span></i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt"> We aimed to help bridge this translational gap by presenting the latest clinical </span></p>
<p style="top:364.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">trials on electrical stimulation for PNIs in combination with relevant etiologies, treatments and nonclinical findings. </span><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Methods.</span></i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt"> </span></p>
<p style="top:376.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">To do so, a systematic search was performed on PubMed, IEEE, and Web of Science databases up to February 2020 using </span></p>
<p style="top:388.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">keywords significant to our study. References of each manuscript were screened for additional manuscripts of relevance </span></p>
<p style="top:400.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">to our study. </span><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Results.</span></i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt"> We found multiple BES clinical studies reporting enhanced functional recovery or increased nerve </span></p>
<p style="top:412.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">regeneration. Although improved outcomes were reported, high variability after BES is seen between and within species likely </span></p>
<p style="top:424.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">due to injury severity, location and timeline along with other factors. </span><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Conclusion.</span></i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt"> Further clinical studies and introduction of </span></p>
<p style="top:436.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">novel delivery platforms are vital to uncover the true regenerative potential of electrical stimulationtherapy.</span></p>
<p style="top:465.3pt;left:63.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Keywords</span></b></p>
<p style="top:477.3pt;left:63.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">electrical stimulation, regeneration, peripheral nerve injury, therapy</span></p>
<img style="position:absolute;transform:matrix(.374269,0,-0,.3851852,-38,-6.666666)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAAAOQAAAAtCAIAAAAx0lCmAAAACXBIWXMAAA7EAAAO
xAGVKw4bAAAQHElEQVR4nO2aCXNUVRbH+Q4zNTVV8wmcUUvHchkdF1xm1Bm1JqAg
Am6IKIsICCqrKyK7AjIKKMgaQpbOnpBOSC/pTqeTTkIWOjshC4TNhSlQ1Pl1n9Th
0f1ep4NQYNX71yu8975zzj33vP8999yOIxrq63OysooLC+3Hfq7ZB4pC1BH85xcb
Nq55QNQR0PZqu2HDxtCAqDZZbfw2YJPVxm8GNllt/GYwSNafLxXnzp8Pn/7e3Xsi
t+toXtcxGq2nvz93/qdLNmjDhhUiZC0qKDg/THxz9lxme98Md8P9Dt/dmRUxz4PZ
/tc9DY72vu/O/jBcyzZsWAGiRsj6Y9L4/uy5TY1dD+dUxnM0/nk0t3JL4+Ez584l
b9+GDSsMkvVccgj2nxhdGEyGpsZnTFF17bGTSU5hw4YVImQtzM8/mwTSW3ruzTI5
9J/elDVv6RdLF6zmoTF2syNeZmSWz9HWm8wsNmxYAaJGyPq/obCjqSuGf49vL9o0
fVHLfY+fvOW+mKdl5BOfz1iCQIxKWrh7yIls2LDCIFnPJERxR6+Rc/dkVnwy58P+
2x+Kp6nx6bvjoVXzPr7HqJhVUdrVl3guGzasECVrXt531mgfOGm8Tv0zx1+SmZuY
psanKDPvAYdf1f+VW9l5/FSC6RKgt7c3Jydnw4YNq1at+vzzz0tKSk6cOGEUCIVC
ZWVl9fX1l2Y/GXR3d5dFMSytY8eOeb1eHMbDK+TY5QUOyzJjInx1AVEjZP3WGnM9
DUo1aOfr7h/ISE+erAh7uvpGGn7hml/RmGA6U3zzzTe7du0aO3ZsysV49tlni4qK
VOz9999nECoP137y4PvJ1MmrdHV1vfDCC6L12muvXTHXLicOHjwoDre3tyepkpub
m5aWRqa4cl5FyFqQm3vaApWHey4qOps7GTyavi95siKMyq7GDqOd6iP9VjOaYs2a
NRK7l19+ecuWLQSF/PrMM8/IYGFhoYi99957dFeuXDks48OC0+mUSZNX2bp1K/JP
PfXU2rVrd+zYceV8u4yoq6uTZba2tiap8tJLLyG/d+/eK+cVRI2Q9ZQFgt6pO/fP
fijrAAybdqBOBvuHQ1aEUTl56tSU0lol68KKBqsZ46H8WLp06cDAgI63tbVJxpo4
cSLHFiNC1hUrViRvfLhQZ5JXwR/kP/jggyvn1WVHbW2tLLOlpSVJFSFramrqlfNq
kKwnzNDdd/gHz02/eK/vc907J+8LX2ePjPen7R0GWdP2ipar/ciFP3E5fD3HBkwn
jQdHJ1GYNGlSf39/zKv09HSJ6YEDB+i+++67QtbOzs6vvvqKqmDZsmXUCcePH79o
Xd3dO3fu/DCKbdu2cdLFmEV99+7d6CJAcVxTU6Ov9u/fLzPqCLlnTxTl5eUxdpqb
mxmfNWsW8nPnzs3Ozq6qqpJX7Lr8/HwqlnfeeWf58uW8Mq6OGVEUz/Py8tilkCA+
Mvv27UOMkzfemaNHj9KtqKgQx9jYrBQ7zJiVlRUfyUAgsH79enYU/1ZWVlJbyzLD
4bA6XFxc/Mknn+Awgd24caOGBfvMMn78eOQ/+ugj1oK6WubTcDDyaThY3G53zLwe
j+ezzz4jzkT7yy+/NK4lHhGy5ufkHDdDoD4VpsrT7X5Yx/v2piZPVoRVcVzRhT8o
FIa7TCeNQVNTk0SNWMe/5crliYKPRFfIOm/evOeee85Y2hKmC4sKBKh0jW8pJ1wu
lwoQ3HHjxsUUx1Qd8lbJKl0SD5UJ3dmzZ1ObxrinwgqowHhHR4cw2AjsNDQ0iCJb
hZE333yTTyhvIXT88qUQcjgcOkIoRP7w4cN0mU58EyYpXn31VTxXLVgS44xEEhw6
dAgByP3222/HyIwaNYrdwlt8i3mFQdGSW4QRCHMMyrzsnJi3o0ePZnNakQGiRsh6
zAwVvkVK1oB/sY73pA6DrAir4uqqZiXrmqpm00ljgOuyDG7TQwqz6UV4/vz5yPv9
fhoyAukRgCXC1EWLFvE2GAx+/PHHdJ9++mm+CgLkQtqMvPXWW7CWRMi+FwtUxgiQ
7aRLGxVhKlkTpsb7gzXSmJwMb7zxBm2SFuPiFVuCWyMjjEs9g7Wenh4EGKc7ZswY
/p0+fTo+5Jh9IyEr6jpC6hL3OBzorlu3TrrPP/88FlgvZ9GECROEwaLCMkWGtEom
9vl85Dllj8RN/IFJNEh+1dXVUtuwBBhJqPFBzJK8aTMRWhI6ijTuXtzYMjMzJQts
3ryZt8RWpmBnUiKTLwij2OToM/2+g2Q9aoZa9/NK1pr63Tp+JDPjxC33JknWXodD
FXOa2pWsc8rrTCeNgeQYQNYZUljISnRYrYwQWVGHZHSpDWi/8sorcEIEiLXE6NNP
P6VLBqX94osvqgWwZMkSBimIaStZOVinTp1Kg5RjFLbyil0hXTaJWCDvqgw14pNP
PskgX5SukAMwdV9fn5VlIauoCPjkSla6SlYmVZnS0lIZhJp0JYmyOQmFxoSuyDQ2
NjLCpZbziqNfjejPBTIRoE6ji+fSpbjiTslIWVmZalEhMDJ27FgSv0SS9CxTiM3N
UZAFTNcbIWtednafGcKu/yhZG1vcOt7lKg3+5U+9N9+eVM3q8amir+3Cn8Eml9SY
ThoDbpcSFHbzkMLKKh2hThD1goICusJLBMoNkMOIrIYAaSwlelgbzRJZQs9XoY0d
MTht2jRJNqTPZLyCrNL9+uuvJdXFiMk5S81Hm5JaZoHECSwLWTMyMnSE5YgiDtNl
B9KeOXNmjKIQi8Oathw1pEOjgB5oEMg4TvHAfuD0h7vGidQmnkuXilwOBzK3hpqq
V7RKSkqIm7AZ7lItkJWo0PheCdYLUSNk7TVDl/tRJWtTa0DHO8ud3ut+V3Hd7w/d
eN2QKbbfXaGKtR2Hlazji4Kmk8aAVcnyOEri3xKpTVHIOoUW1HlGGSUrbbmxmoIt
joCcZQTOyh8lq6jwL4dm4iXEeCUEoiqIEZM9Q51Ke8eOHSnRYjqxZSErJ7uO6JlO
4qfLfSg+IIBZGOfeQ1tWQbo1ClCciB2Opt5onBE21vr6m7dMBISseC5d3W+mEJ85
W0RLwR4mPVmtN0LW3OzsI2Zoco1WsjY0l+t4+4ESyCrPkCm21+VRRU+4w5BZq00n
jQGxkPORzRf/ljpSFkms6S5evDglmpyMMiJAqqDNxSIlmlnzzICA3MxIOVb+aMqB
o9u3bzcat0KMVxymKdHEHCMmd5GFCxfSFst8yMTBEbKS53REj3hSIF0hKw7EKEoB
w7ahLXUkh7JRQK+GVJN0Zb9RzeM8KZNyU5OITASEdngu3T179sh+Mw01e0DEqKCo
RjhtmEI3QLYFIXOFrN1mqHZPUrJWhbbreHvZfiWrpNjwjX+2SrE95W5VzKwPK1ln
lYVMJ42H1PskANKGcZzTWY5OIsLNiRGlhVFM+URbfoiliDQKcKVIS0uD97Ql5XD9
MgqIWaJJW8lKVYADcqkn5VBmWfkf45XUbdQP1Goqo3/lgg10pVTg8yeOjJCVMlFH
9Le8cDhMd+3atbQ5LkiNKoOrsv85QOi+/vrrtLkMGS1L7Z4SrUPQleybmpqqAnrC
yERAyIrn0tXqmeNetTCVFgVawlGHw6FvkeS2kBI9CkzXO0jWLjO4vIuVrJUVC3S8
1VlkJKs8dY/cPfDYmHiydpe5VHF5Rb2SdYXvoOmk8QiFQrL72dns19bWVgappbh4
SjgoA0QSkqVEL6RGdZHhLkybWkJ4T6zlLXYmT57MIHcRupIPECB/iACVlnxaeEAX
O2JQ3kJ0aBc/qRExXpGKpNggicpa4L2wink5fxnZtm1bSvSelzgy3BRTor9FsFfp
wkL55UEowoj+5U9+e2YEukgKx22yps5FbN1uty5Zk1xNTQ0OS3vr1q26BL2BkSNl
UMgK6aXLdFJ0cYHjeDQuk72NG9A0JVpOUMKp2SlTpqREf2o0XW+ErDkOR6cZXNW7
laxH3P/Q8RZn4UWZ9YY/1n+0sLOtjadv2ZqTtz1wEVlLy1VxbEFAyZpVd8h0UlNw
SGn4iDIZRfa6fHK5/QClhVFXTxbafFQ50VKiPwlxS5Cfhwg0eQ4BTMnVAftkTSpL
4SINdBGQvCiZVaBJiKRr6ny8V0jKBpg4cSKHg1bS7DoRULImDgsXZ1HEfyhLWOR3
t5ToT04ICFllEB6Q47VG5BIpRtgwellkmXPmzGHtaod7LTJ6nZoxY8b8+fP1D92A
KIkMumKELcSeZ4TrlCyT4oojS6bGuHwLpabMC/tlD/NF/H6/6XohaoSs7WZoCDef
8dyqfA2G0mX80P4CZWrgsb+HS4uNWl3OsoFRE5SsdGU8v/7Cj6wPOHxNrW2mk1qB
Ook9KvdHASHYsmULsVYZjg8+MPvSqPhiFKRS6RIjdr/+SE6kMEvyVnlOKIo5/R7M
uHz5cqgsb7EjBo3ynKSM8Nlox3tO7cHJQG4zDjqdTuR1y/HZOBz1LZUfKlSWiWPC
WjAr2wnAs4yMDHFPHF69erXsNE5w/Z9p2PZsMGPc5JjS2MJdXSaZFQFyMFtOvOVf
1ssZpX8m8Hg8yFCkQWWMIID/YpkaWtgvkjNnziTv6LyEnZJM/UeMXUH9YLXeQbK2
WcDnmqpkbXFz9Wtl8FBxfoSp1/+h7sMFbeGwiVo43Lt01clb74esnSWlbVG1ScVV
StZ5ZTVWMyYGCYPTii3L+Uu4L80I4DOzfb1eLwatBNgezMLZesmzDImGhgbOfajw
a4xANT5wMBiMfyVkhS60CRcrolKkQjC1w0pxhiLVaiI2ABaMEWPSZJxHBUUWazUv
ceZzDBnqCFmzs7JaLOAOFf3svUH5WuFfyWBTYW7lo3fwr5WWoKOweOCJcR3FTtpf
+C9Uqzwl9U2JdW1cFsjPYZD1ajtyeQBRI2QNW8PvekXJ+qP3Jn8w9VBdbbipMYGK
oqWhsaW+vjyY/W+HU5k62xlMRtfGr8fKlSuFrFfbkcuDKFkzM5utUVnnP+m+U/l6
1vNXb2BbAvkYeAJbUTnuvmtB/nqY+ki2z3ewMXl1G78G1I4LFiygBL/ajlweQNQI
WZsSwlm567z3RuXrT94bfJ65BxuqE2vVH6z2uecYq4jy0gl7q0KJtWzYsMIgWRuG
QqFn/U8G2vGcct/p8SypCpXGCwdCTo978beeO4zyPAe8q4acyIYNK0TI6sjIOJgE
ir0bz3pujuFf5H/Ndt9f55oYcE2rdE2vc03od4+Ml6HYLfWuT2YWGzasAFEjZK1L
Dk5/VofrkXguJn6OuB4sr0x2Chs2rDBI1tqkURWqLnYtPem+Kxmannb/zel6Pxiq
St6+DRtWiJA1Kz29ZpioCAYK3RuqDjz7nee2eI6e8dxaUz6h2L2usrpyuJZt2LAC
RI2QtfpSURkMOv0FRZ5tBe7/8hR7tjr9+YFg8JIN2rBhhQhZM9PTq2zYuOaRKWQN
2LBxzWOQrH4bNq55RMiasW+fz4aNax4QdcTePXu8Nmxc84CoI+pCIf4Dbe3Hfq7Z
B4pC1P8DETYLZ5tlVDMAAAAASUVORK5CYII=">


<p style="top:40.8pt;left:48.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">980 </span></p>
<p style="top:40.8pt;left:365.8pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Neurorehabilitation and Neural Repair 34(11)</span></i></p>
<p style="top:67.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">&#x201c;stimulation&#x201d; or &#x201c;bioelectric&#x201d; or &#x201c;electrotherapy&#x201d; or &#x201c;elec-</span></p>
<p style="top:79.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">trode&#x201d;) and (&#x201c;peripheral&#x201d; or &#x201c;nervous&#x201d; or &#x201c;system&#x201d; or </span></p>
<p style="top:91.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">&#x201c;nerve&#x201d; or &#x201c;neural&#x201d;) and (&#x201c;repair&#x201d; or &#x201c;regenerate&#x201d; or </span></p>
<p style="top:103.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">&#x201c;restore&#x201d; or &#x201c;function&#x201d; or &#x201c;enhance&#x201d; or &#x201c;restore&#x201d; or &#x201c;heal&#x201d;) </span></p>
<p style="top:115.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and (&#x201c;injury&#x201d; or &#x201c;insult&#x201d; or &#x201c;lesion&#x201d; or &#x201c;trauma&#x201d; or &#x201c;lacera-</span></p>
<p style="top:127.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion&#x201d; or &#x201c;compression&#x201d; or &#x201c;crush&#x201d;). References of each arti-</span></p>
<p style="top:139.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cle were screened for additional articles of relevance to our </span></p>
<p style="top:151.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">study. Two investigators independently filtered each article </span></p>
<p style="top:163.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">according to title and abstract and included any article relat-</span></p>
<p style="top:175.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ing to the translation of brief electrical stimulation (BES) for </span></p>
<p style="top:187.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">enhancing peripheral nerve regeneration after injury. The </span></p>
<p style="top:199.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">full text of each selected article was obtained and analyzed. </span></p>
<p style="top:211.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Institutional review board approval and Institutional Animal </span></p>
<p style="top:223.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Care and Use Committee approval were not required due to </span></p>
<p style="top:235.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lack of patient information or animals involved in this study.</span></p>
<p style="top:264.3pt;left:48.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">PNI Classifications</span></b></p>
<p style="top:283.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">The Seddon and Sunderland classification systems are </span></p>
<p style="top:295.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">widely used to define PNIs. This review will use the </span></p>
<p style="top:307.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Sunderland system due the added assessment of regenera-</span></p>
<p style="top:319.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tive ability by addressing continuity of nerve sheath lay-</span></p>
<p style="top:331.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ers.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">8,9</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> A first-degree injury is the least severe and defined by </span></p>
<p style="top:343.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">focal demyelination (neuropraxia) of the intact nerve with </span></p>
<p style="top:355.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">no axon loss. Additional axon loss (axonotmesis) in second-</span></p>
<p style="top:367.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">degree lesion is the only differentiator from first degree, but </span></p>
<p style="top:379.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">both will most likely achieve full recovery. Injuries of the </span></p>
<p style="top:391.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">third- to fifth-degree are characterized by additional loss of </span></p>
<p style="top:403.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">adjacent connective tissue layers from inner to outermost.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">9,10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:415.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Damage of the endoneurium in third-degree injury disrupts </span></p>
<p style="top:427.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">the scaffold by which axons elongate thus impairing regen-</span></p>
<p style="top:439.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eration and causing neuroma formation, and the perineurium </span></p>
<p style="top:451.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and fascicular arrangement are preserved. Variable outcomes </span></p>
<p style="top:463.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">are seen following third-degree lesion. Neuroma formation </span></p>
<p style="top:475.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and inhibited regeneration occur in fourth-degree injury due </span></p>
<p style="top:487.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in part to additional perineurial damage, which results in </span></p>
<p style="top:499.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">poor recovery; however, the epineurium remains intact in </span></p>
<p style="top:511.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">fourth-degree injury. Unlike first- to fourth-degree lesions, </span></p>
<p style="top:523.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">fifth-degree injury is characterized by complete nerve tran-</span></p>
<p style="top:535.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">section and discontinuity, which result in poor functional </span></p>
<p style="top:547.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">recovery.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">9,10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Standards of care for both neuroma-in-continu-</span></p>
<p style="top:559.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ity (third and fourth degree) and complete transection (fifth </span></p>
<p style="top:571.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">degree) include surgical repair to promote regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup></p>
<p style="top:600.3pt;left:48.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Obstacles to Functional Nerve Repair</span></b></p>
<p style="top:619.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">For many PNIs, surgical intervention is necessary to allow </span></p>
<p style="top:631.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">functional regeneration. Substantial advances have been </span></p>
<p style="top:643.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">made in peripheral nerve surgery over the years with addi-</span></p>
<p style="top:655.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion of techniques, including microsurgery, nerve grafting, </span></p>
<p style="top:667.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and intraoperative electrophysiology. Clinical results ini-</span></p>
<p style="top:679.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tially improved but have since plateaued. Indeed, promising </span></p>
<p style="top:691.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">new strategies, such as nerve transfer, have provided sur-</span></p>
<p style="top:703.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">geons the ability to overcome previous limitations in treat-</span></p>
<p style="top:715.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ment.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">11</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Reports showing inadequate functional recovery </span></p>
<p style="top:67.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">after surgical repair of various PNIs remain prevalent </span></p>
<p style="top:79.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">despite these advances. A 2005 meta-analysis was per-</span></p>
<p style="top:91.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">formed to identify predictors for motor and sensory recov-</span></p>
<p style="top:103.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ery after microsurgical repair of median and ulnar nerve </span></p>
<p style="top:115.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">transection lesions.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">5</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Identical to early reports by Sunderland </span></p>
<p style="top:127.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">from his 40 years on nerve repair, meta-analysis revealed </span></p>
<p style="top:139.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">the 3 significant predictors of successful motor recovery </span></p>
<p style="top:151.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">include patient age, site of lesion, and delay in repair. Only </span></p>
<p style="top:163.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">patient age and delayed repair were found to be significant </span></p>
<p style="top:175.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">predictors of sensory recovery. Meta-analysis of median </span></p>
<p style="top:187.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and ulnar nerve transection repair interestingly found only </span></p>
<p style="top:199.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">51.6% and 42.6% of repairs achieve satisfactory motor and </span></p>
<p style="top:211.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sensory recovery, respectively.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">5</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Despite extensive elucida-</span></p>
<p style="top:223.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion of the mechanisms for PNI and regeneration, a lack of </span></p>
<p style="top:235.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">dependable therapeutic strategies to fully restore function </span></p>
<p style="top:247.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">after injury still persists.</span></p>
<p style="top:274.3pt;left:303.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Brief Electrical Stimulation to Enhance </span></b></p>
<p style="top:288.3pt;left:303.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Peripheral Nerve Regeneration</span></b></p>
<p style="top:307.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Countless therapies, including neurotrophic factors, nerve </span></p>
<p style="top:319.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">conduits, neural scaffolds, gene therapy, stem cells, and more </span></p>
<p style="top:331.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">continue to be investigated for their potential to restore nerve </span></p>
<p style="top:343.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">function after PNI. Of these strategies, electrical stimulation </span></p>
<p style="top:355.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">(ES) has emerged a frontrunner. The safety of ES on periph-</span></p>
<p style="top:367.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eral nerves has been established in humans,</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">12</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> while sensory </span></p>
<p style="top:379.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">feedback in upper limb amputation and neuropathic pain </span></p>
<p style="top:391.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">relief with ES have been effective.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">13,14</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> In 1952, the first ani-</span></p>
<p style="top:403.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">mal study on ES of peripheral nerves by Hoffman et al </span></p>
<p style="top:415.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">revealed accelerated axon sprouting into partially denervated </span></p>
<p style="top:427.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">muscle. Investigation by others would later show the ability of </span></p>
<p style="top:439.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ES on the proximal nerve stump to enhance target reinnerva-</span></p>
<p style="top:451.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">15-18</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> and/or axon regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">18,19</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Similar combined </span></p>
<p style="top:463.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">efforts elucidated effective ES durations and frequencies for </span></p>
<p style="top:475.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nonharmful treatment in animals. A single dose of BES of </span></p>
<p style="top:487.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injured nerves at 20 Hz for 1 hour was found as effective in </span></p>
<p style="top:499.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">accelerating sensorimotor regeneration than stimulation with </span></p>
<p style="top:511.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">higher frequency and/or longer duration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">19-22</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> These reports are </span></p>
<p style="top:523.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">upheld by the many studies on BES enhancement of nerve </span></p>
<p style="top:535.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration in animals which have followed.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">4,23</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> The mecha-</span></p>
<p style="top:547.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nism of action contributing to the success of BES involves an </span></p>
<p style="top:559.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ES-induced increased production of neurotrophic factors and </span></p>
<p style="top:571.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">upregulation of their receptors.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">19,22,24</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Specifically, increased </span></p>
<p style="top:583.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">production of brain-derived neurotrophic factor (BDNF) and </span></p>
<p style="top:595.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration-associated factors (RAFs) including Talpha-1 </span></p>
<p style="top:607.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tubulin and GAP-43 may increase neural plasticity and accel-</span></p>
<p style="top:619.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">erate axonal regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">19,22,24</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> In addition, ES has been </span></p>
<p style="top:631.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">shown to upregulate neurotrophin 4/5, which has been corre-</span></p>
<p style="top:643.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lated with increased nerve regrowth in mice.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">25</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Despite encour-</span></p>
<p style="top:655.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">aging results in animals and established safety in humans, </span></p>
<p style="top:667.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">only a few studies on BES to enhance peripheral nerve regen-</span></p>
<p style="top:679.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eration have been performed in a clinical setting. In this </span></p>
<p style="top:691.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">review, we present the latest BES clinical trials in combina-</span></p>
<p style="top:703.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion with a background to relevant etiologies, standards of </span></p>
<p style="top:715.9pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">care and BES animal studies.</span></p>


<p style="top:40.8pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Ransom et al </span></i></p>
<p style="top:40.8pt;left:540.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">981</span></p>
<p style="top:67.6pt;left:63.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Clinical Study 1: BES Accelerates Target </span></i></p>
<p style="top:81.6pt;left:63.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Reinnervation After Chronic Nerve Compression</span></i></p>
<p style="top:101.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Introduction to Compression Injury. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Compressive neuropathies </span></p>
<p style="top:113.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">are among the most prevalent nerve lesions seen within a </span></p>
<p style="top:125.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">clinical setting (source). Compression injuries commonly </span></p>
<p style="top:137.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">occur where nerves pass through narrow anatomical open-</span></p>
<p style="top:149.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ings resulting in focal demyelination (first-degree injury).</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10,26</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:161.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Unlike acute compression, untreated chronic compression </span></p>
<p style="top:173.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">may progress to axonal damage or axonotmesis (second-</span></p>
<p style="top:185.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">degree injury) causing denervation atrophy of target muscle, </span></p>
<p style="top:197.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">as seen in severe carpal tunnel syndrome (CTS).</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">7,26</span></sup></p>
<p style="top:218.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES After Delayed Repair in Rats. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Initial studies in rats </span></p>
<p style="top:230.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">revealed chronic denervation of distal stump and target </span></p>
<p style="top:242.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">muscle impair functional regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">7</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Two different stud-</span></p>
<p style="top:254.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ies have investigated the potential of BES to enhance axo-</span></p>
<p style="top:266.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nal regeneration after chronic axotomy repair in rats. Huang </span></p>
<p style="top:278.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">27</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> and Elzinga et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">28</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> concluded that BES accelerates </span></p>
<p style="top:290.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">axon regeneration and increases target reinnervation of </span></p>
<p style="top:302.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">motor and sensory neurons after a 4- and 3-month delay, </span></p>
<p style="top:314.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">respectively, in axotomy repair. In addition, Huang reported </span></p>
<p style="top:326.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">the same treatment was effective in promoting functional </span></p>
<p style="top:338.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">recovery after a 4-month delay in repair of chronically axot-</span></p>
<p style="top:350.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">omized neurons.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">27</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> These novel findings reveal the thera-</span></p>
<p style="top:362.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">peutic potential of BES to stimulate functional recovery </span></p>
<p style="top:374.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">after chronic axonotmesis. However, while much of the cur-</span></p>
<p style="top:386.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">rent literature investigates delayed repair following acute </span></p>
<p style="top:398.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">compression, additional studies are required to better under-</span></p>
<p style="top:410.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">stand the implications of chronic compression.</span></p>
<p style="top:431.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Chronic CTS Diagnosis and Standard of Care. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Carpal tunnel syn-</span></p>
<p style="top:443.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">drome (CTS) is the most prevalent compression lesion and </span></p>
<p style="top:455.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">initially presents as recurrent nocturnal paresthesias and dyses-</span></p>
<p style="top:467.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">thesias.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Progression of CTS may cause loss of sensation and, </span></p>
<p style="top:479.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ultimately, thenar motor function in moderate to severe cases. </span></p>
<p style="top:491.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">For a CTS patient with mild symptoms and no axonal loss </span></p>
<p style="top:503.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">(first-degree injury), nonsurgical treatment options are stan-</span></p>
<p style="top:515.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">dard. In late-stage CTS (second-degree injury), symptoms of </span></p>
<p style="top:527.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">axonal loss are present thus necessitating surgical release of the </span></p>
<p style="top:539.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">transverse carpal ligament.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Carpal tunnel release surgery </span></p>
<p style="top:551.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">(CTRS) is known to be highly effective, but lack of symptom </span></p>
<p style="top:563.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">improvement and prolonged recovery may occur due to exten-</span></p>
<p style="top:575.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sive axonal loss prior to treatment.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6,7</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Therapeutic strategies to </span></p>
<p style="top:587.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">accelerate or increase median nerve regeneration in chronic </span></p>
<p style="top:599.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">CTS would undoubtedly have profound implications.</span></p>
<p style="top:620.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES Accelerates Median Nerve Regeneration After CTRS. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">While </span></p>
<p style="top:632.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">surgical intervention of CTS may ameliorate symptoms, </span></p>
<p style="top:644.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">many individuals continue to experience sensorimotor </span></p>
<p style="top:656.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">impairment thereafter.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Given the variation in etiologies and </span></p>
<p style="top:668.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">outcomes of CTS, further studies are needed to explore com-</span></p>
<p style="top:680.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">binations of both diagnostic and therapeutic modalities.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">29,30</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:692.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">In a 2007 clinical trial, it was reported that patients receiving </span></p>
<p style="top:704.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">BES after CTRS had higher estimated numbers of intact </span></p>
<p style="top:716.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">motor units compared with unstimulated patients after 6 </span></p>
<p style="top:67.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">months and up to 12 months.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">31</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> These differences between </span></p>
<p style="top:79.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">treatment and control groups were indeed significant and </span></p>
<p style="top:91.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">suggest BES leads to accelerated regeneration and target </span></p>
<p style="top:103.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">reinnervation after chronic median nerve entrapment. A fol-</span></p>
<p style="top:115.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">low-up study was performed in 2010 to further determine the </span></p>
<p style="top:127.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">efficacy of BES in treating severe CTS.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">32</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Despite no observed </span></p>
<p style="top:139.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">difference in functional outcomes between groups, this trial </span></p>
<p style="top:151.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">confirmed that BES immediately following decompression </span></p>
<p style="top:163.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">surgery in patients suffering from severe CTS results in early </span></p>
<p style="top:175.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and complete reinnervation of thenar muscles by regenerat-</span></p>
<p style="top:187.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ing axons. Individuals undergoing CTRS alone did not show </span></p>
<p style="top:199.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">significant muscle reinnervation. It should be noted that the </span></p>
<p style="top:211.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lack of difference in motor performance may have been due </span></p>
<p style="top:223.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">to inadequate characterization of thenar motor function by </span></p>
<p style="top:235.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tests performed in this study.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">33</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Further investigation into </span></p>
<p style="top:247.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">whether BES improves motor function in severe CTS is war-</span></p>
<p style="top:259.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ranted. These findings endorse the use of BES as an adjunct </span></p>
<p style="top:271.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">therapy after CTRS for accelerating median nerve regenera-</span></p>
<p style="top:283.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">32</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> A contemporary study conducted by Power et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">34</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> in </span></p>
<p style="top:295.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">2020 extended these findings from CTRS to cubital tunnel </span></p>
<p style="top:307.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">syndrome and found that postsurgical ES may be effective in </span></p>
<p style="top:319.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">enhancing muscle reinnervation and recovery following sur-</span></p>
<p style="top:331.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">gery. Further research is required to fully understand the lim-</span></p>
<p style="top:343.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">its of ES in patients with compressive neuropathies.</span></p>
<p style="top:369.3pt;left:318.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Clinical Study 2: BES Accelerates Recovery </span></i></p>
<p style="top:383.3pt;left:318.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">of Sensory Function After Complete Nerve </span></i></p>
<p style="top:397.3pt;left:318.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Transection</span></i></p>
<p style="top:416.9pt;left:318.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Introduction to Transection Injury. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Poor functional outcomes in </span></p>
<p style="top:428.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">peripheral nerve repair continue to persist in the face of surgi-</span></p>
<p style="top:440.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cal advancement. This phenomenon is largely due to dramatic </span></p>
<p style="top:452.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">variation in the regenerative abilities of specific nerve lesions. </span></p>
<p style="top:464.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">The presence of an intact endoneurial tube, as seen in second-</span></p>
<p style="top:476.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">degree lesions, provides an optimal environment for axonal </span></p>
<p style="top:488.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regrowth which leads to better outcomes in nerve regenera-</span></p>
<p style="top:500.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">26</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Transection injury or neurotmesis is characterized by </span></p>
<p style="top:512.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">complete discontinuation of the peripheral nerve (fifth-degree </span></p>
<p style="top:524.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injury) and commonly occurs due to laceration from knives, </span></p>
<p style="top:536.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">glass, bullets, and so on</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">26</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> in the setting of an open injury.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:548.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Prompt recognition and surgical repair of transection injuries </span></p>
<p style="top:560.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">are critical for achieving the best possible outcomes. Despite </span></p>
<p style="top:572.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">early intervention, outcomes may be negatively affected by </span></p>
<p style="top:584.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">factors outside the surgeon&#x2019;s control, including patient age, </span></p>
<p style="top:596.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">target reinnervation distance, and time from injury to presen-</span></p>
<p style="top:608.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tation.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Increases in each of the aforementioned parameters </span></p>
<p style="top:620.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">have shown to adversely affect nerve regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup></p>
<p style="top:643.9pt;left:318.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES After Complete Nerve Transaction. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Despite the elucida-</span></p>
<p style="top:655.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion of mechanisms for nerve injury and regeneration, a sig-</span></p>
<p style="top:667.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nificant lack of reliable therapy for enhancing nerve </span></p>
<p style="top:679.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration still remains. Early in the new millennium, Al-</span></p>
<p style="top:691.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Majed et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">17</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> determined that a single delivery of continu-</span></p>
<p style="top:703.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ous 20-Hz electric stimulation for 1 hour (BES) after nerve </span></p>
<p style="top:715.9pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">repair is equally as effective in accelerating motoneuron </span></p>


<p style="top:40.8pt;left:48.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">982 </span></p>
<p style="top:40.8pt;left:365.8pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Neurorehabilitation and Neural Repair 34(11)</span></i></p>
<p style="top:67.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration as stimulation for 2 weeks&#x2019; duration. Later </span></p>
<p style="top:79.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">studies demonstrated how BES treatment is equally effec-</span></p>
<p style="top:91.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tive in accelerating sensory regeneration as stimulation with </span></p>
<p style="top:103.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">higher frequency and/or longer duration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">20-22</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> The ability of </span></p>
<p style="top:115.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">such a simple, acute therapy to enhance both motor and sen-</span></p>
<p style="top:127.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sory regeneration in rats reveals an exciting potential strat-</span></p>
<p style="top:139.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">egy for accelerating nerve regeneration in humans.</span></p>
<p style="top:163.9pt;left:48.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Nerve Transection Diagnosis and Standard of Care. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Early </span></p>
<p style="top:175.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">management of traumatic nerve injury is essential for resto-</span></p>
<p style="top:187.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ration of nerve function. Patients with traumatic nerve </span></p>
<p style="top:199.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injury usually present with a motor, sensory, or pain deficit </span></p>
<p style="top:211.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">immediately following the inciting event. While historical </span></p>
<p style="top:223.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">information may provide insight to mechanism of injury, </span></p>
<p style="top:235.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">detailed documentation of initial neurological examination </span></p>
<p style="top:247.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">is critical to establishing a comparative baseline.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Traumatic </span></p>
<p style="top:259.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injuries are generally classified as open or closed.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Open </span></p>
<p style="top:271.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injuries commonly result in neurotmesis, but timing of sur-</span></p>
<p style="top:283.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">gical intervention is dependent on presence of either sharp </span></p>
<p style="top:295.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">or ragged transection.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Primary repair of ragged transec-</span></p>
<p style="top:307.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tions from blast, gunshot, fracture, or crush injury should be </span></p>
<p style="top:319.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">delayed for approximately 3 weeks to allow demarcation of </span></p>
<p style="top:331.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nerve ends. Sharp transections from knives or razors should </span></p>
<p style="top:343.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">be surgically repaired within 3 days of trauma.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6,10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Due to the </span></p>
<p style="top:355.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">limited time frame for functional repair of sharp transec-</span></p>
<p style="top:367.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion, delayed intervention often leads to incomplete motor </span></p>
<p style="top:379.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and sensory recovery.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Therapeutic enhancement of regen-</span></p>
<p style="top:391.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eration may provide a larger window for repair and func-</span></p>
<p style="top:403.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tional restoration after peripheral nerve transection.</span></p>
<p style="top:427.9pt;left:48.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES Enhances Sensory Function After Digital Nerve Transection </span></i></p>
<p style="top:439.9pt;left:48.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Repair. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">The potential for BES to improve sensory regeneration </span></p>
<p style="top:451.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">after repair of transected digital nerves was assessed in humans. </span></p>
<p style="top:463.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Wong et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">35</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> recruited 36 patients with complete digital nerve </span></p>
<p style="top:475.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">transection to participate in a randomized, double-blind pla-</span></p>
<p style="top:487.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cebo-controlled trial to determine whether BES after surgery </span></p>
<p style="top:499.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">results in improved digit tip sensation and functional outcomes </span></p>
<p style="top:511.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">compared to surgery alone. Within 14 days of injury, patients </span></p>
<p style="top:523.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in the treatment group underwent epineural nerve repair imme-</span></p>
<p style="top:535.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">diately followed by BES. Sensory function and functional dis-</span></p>
<p style="top:547.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ability were assessed monthly up to 6 months after surgery. </span></p>
<p style="top:559.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Disability from the nerve injury was monitored and graded </span></p>
<p style="top:571.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">using the Disability of Arm, Shoulder and Hand (DASH) </span></p>
<p style="top:583.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Questionnaire, while sensory function was analyzed via 3 dif-</span></p>
<p style="top:595.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ferent modalities, including temperature threshold, tactile dis-</span></p>
<p style="top:607.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">crimination, and pressure detection. A trend of greater </span></p>
<p style="top:619.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">functional improvements in the BES group was seen though it </span></p>
<p style="top:631.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">was not statistically significant likely due to small sample size. </span></p>
<p style="top:643.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Unlike the control group, BES-treated patients experienced </span></p>
<p style="top:655.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">significant and near complete recovery of all sensory modali-</span></p>
<p style="top:667.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ties by 5 to 6 months compared with baseline.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">35</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> BES enhance-</span></p>
<p style="top:679.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ment of sensory regeneration in patients with complete digital </span></p>
<p style="top:691.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nerve transection argues for further clinical application after </span></p>
<p style="top:703.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">complete nerve transection repair.</span></p>
<p style="top:67.6pt;left:303.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Clinical Study 3: Intraoperative Brief ES of CN </span></i></p>
<p style="top:81.6pt;left:303.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">XI Preserves Shoulder Function in Patients </span></i></p>
<p style="top:95.6pt;left:303.0pt;line-height:12.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Undergoing Oncologic Neck Dissection</span></i></p>
<p style="top:115.2pt;left:303.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Intro to Crush Injury. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Crush injuries usually occur as a result </span></p>
<p style="top:127.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">of acute compressive trauma by blunt objects such as a bat, </span></p>
<p style="top:139.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">clamps, or others. Extent of nerve damage and classifica-</span></p>
<p style="top:151.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion grade in crush injury are highly variable and dependent </span></p>
<p style="top:163.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">on the amount of compressive force. Thus, crush injuries </span></p>
<p style="top:175.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">may be classified at any level of the Sunderland system </span></p>
<p style="top:187.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">except fifth-degree due to lack of transection in crush </span></p>
<p style="top:199.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">injury.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">26</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Since crush lesions involve structural damage </span></p>
<p style="top:211.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ranging from focal demyelination to neuroma-in-continu-</span></p>
<p style="top:223.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ity, these lesions are difficult to manage and require exten-</span></p>
<p style="top:235.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sive follow-up before proper treatment can be determined.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6,36</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> </span></p>
<p style="top:247.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Even so, multiple factors, including delayed repair, proxi-</span></p>
<p style="top:259.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">mal lesion location, and age may negatively affect func-</span></p>
<p style="top:271.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tional outcomes.</span></p>
<p style="top:295.2pt;left:303.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES After Acute Crush Injury in Rats. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Many traumatic nerve </span></p>
<p style="top:307.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lesions do not completely transect the nerve but leave the </span></p>
<p style="top:319.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nerve in continuity with poor functional recovery due to </span></p>
<p style="top:331.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">inadequate regeneration and reinnervation. To address this </span></p>
<p style="top:343.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">concern, ability of BES to improve outcomes in a rat sciatic </span></p>
<p style="top:355.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">neuroma-in-continuity and facial nerve crush lesion were </span></p>
<p style="top:367.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">assessed. A significant improvement in locomotor function </span></p>
<p style="top:379.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">was seen in BES-treated rats after neuroma-in-continuity </span></p>
<p style="top:391.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lesion at 4, 6, and 8weeks postsurgery, tibialis anterior com-</span></p>
<p style="top:403.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">pound muscle action potential at 8 weeks was significantly </span></p>
<p style="top:415.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">greater in the BES group. By 12 weeks, there was no sig-</span></p>
<p style="top:427.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nificant behavioral or electrophysiologic difference between </span></p>
<p style="top:439.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">the 2 groups.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">36</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Single-session BES effect on facial nerve </span></p>
<p style="top:451.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">function and synkinesis after acute crush injury was </span></p>
<p style="top:463.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">assessed in rats. Amplitude of whisking after injury was </span></p>
<p style="top:475.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">used to assess motor function. Target-specific muscle rein-</span></p>
<p style="top:487.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nervation was measured by injecting neurotracers into buc-</span></p>
<p style="top:499.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cal and marginal mandibular branches of facial nerve at 3 </span></p>
<p style="top:511.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">months postinjury. Although no difference of double-</span></p>
<p style="top:523.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">labeled motoneurons was seen, BES significantly improved </span></p>
<p style="top:535.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">whisking capacity 2 and 4 weeks post&#x2013;crush injury. Similar </span></p>
<p style="top:547.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">to previous reports, no difference in functional outcomes </span></p>
<p style="top:559.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">was seen over the long term. Although short regeneration </span></p>
<p style="top:571.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">distances in rat models ultimately lead to similar outcomes </span></p>
<p style="top:583.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in BES and control groups, the stated findings support the </span></p>
<p style="top:595.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">role of BES in accelerating functional recovery after acute </span></p>
<p style="top:607.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">crush injury. Were BES found to expedite restoration of </span></p>
<p style="top:619.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sensorimotor function in humans it would an invaluable </span></p>
<p style="top:631.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">adjuvant therapy.</span></p>
<p style="top:655.2pt;left:303.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Acute Crush Injury Diagnosis and Standard of Care. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Proper </span></p>
<p style="top:667.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">diagnosis of traumatic nerve injury requires early assess-</span></p>
<p style="top:679.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ment with a detailed neurological examination and thor-</span></p>
<p style="top:691.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ough history.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">6</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Crush injury due to blunt trauma may present </span></p>
<p style="top:703.2pt;left:303.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in either an open or closed setting. After confirmation of </span></p>


<p style="top:40.8pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Ransom et al </span></i></p>
<p style="top:40.8pt;left:540.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">983</span></p>
<p style="top:212.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in-continuity injury, crush injuries are followed for a period </span></p>
<p style="top:224.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">of 3 to 6 months before potential treatment, unlike transec-</span></p>
<p style="top:236.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion, during which physical examinations and electrodiag-</span></p>
<p style="top:248.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nostic studies may document recovery.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Delayed treatment </span></p>
<p style="top:260.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">is necessary to allow either neuroma formation so damaged </span></p>
<p style="top:272.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nerve can be properly resected at the time of repair or spon-</span></p>
<p style="top:284.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">taneous recovery of crushed nerve. It should be noted the </span></p>
<p style="top:296.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">therapeutic window for surgical repair is narrow and wait-</span></p>
<p style="top:308.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ing too long before intervention may lead to suboptimal </span></p>
<p style="top:320.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">outcomes.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">10</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Considered with the regenerative variability </span></p>
<p style="top:332.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">seen among crush lesions, avoidance of surgical repair by </span></p>
<p style="top:344.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">promoting spontaneous recovery of crushed nerves with </span></p>
<p style="top:356.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">BES may be a valuable therapeutic strategy to improve </span></p>
<p style="top:368.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">outcomes.</span></p>
<p style="top:392.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">BES Improves Functional Outcomes After Head and Neck Can-</span></i></p>
<p style="top:404.2pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">cer Dissection. </span></i><span style="font-family:Times New Roman,serif;font-size:10.0pt">Head and neck cancer (HNC) commonly </span></p>
<p style="top:416.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">occurs in the third or fourth decade of life, thus treatment </span></p>
<p style="top:428.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">options should take functional preservation into account for </span></p>
<p style="top:440.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">the many potential work years remaining for patients with </span></p>
<p style="top:452.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">HNC. Treatment options for advanced HNC include pri-</span></p>
<p style="top:464.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">mary surgical resection involving oncologic level IIB with </span></p>
<p style="top:476.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">or without level V depending on presence of malignancy in </span></p>
<p style="top:488.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">adjacent lymph nodes. In level IIB dissection, the spinal </span></p>
<p style="top:500.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">accessory nerve (SAN) is manipulated and often devascu-</span></p>
<p style="top:512.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">larized leading to impaired nerve function and subsequent </span></p>
<p style="top:524.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">37</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> HNC postoperative shoulder pain and dys-</span></p>
<p style="top:536.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">function due to SAN axonal injury are well documented and </span></p>
<p style="top:548.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">have detrimental effects on quality of life.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">38,39</span></sup></p>
<p style="top:560.2pt;left:75.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">In this double-blind randomized control trial, Barber </span></p>
<p style="top:572.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">40</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> analyzed the efficacy of BES of the SAN in reducing </span></p>
<p style="top:584.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">shoulder dysfunction of HNC patients following level IIB </span></p>
<p style="top:596.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:MathematicalPiLTStd,serif;font-size:10.0pt">&#xb1;</span><span style="font-family:Times New Roman,serif;font-size:10.0pt"> level V dissection. The well-established Constant-Murley </span></p>
<p style="top:608.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">score was used to assess both objective and subjective mea-</span></p>
<p style="top:620.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">sures of shoulder function, including pain, activities of daily </span></p>
<p style="top:632.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">living, range of motion, and strength.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">40</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> Primary outcomes </span></p>
<p style="top:644.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">were measured using Constant-Murley score scores at 12 </span></p>
<p style="top:656.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">months postdissection compared with baseline. It should be </span></p>
<p style="top:668.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">noted that spontaneous recovery after crush lesion appears </span></p>
<p style="top:680.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">between 3 and 6 months after injury. Secondary outcomes </span></p>
<p style="top:692.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">were assessed by measuring changes in Neck Dissection </span></p>
<p style="top:704.2pt;left:63.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Impairment Index and compound muscle action potential </span></p>
<p style="top:212.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">amplitude scores over the same timeline. Primary outcomes </span></p>
<p style="top:224.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">but not secondary outcomes were significantly greater in </span></p>
<p style="top:236.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">BES-treated patients compared with patient baseline. It is </span></p>
<p style="top:248.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">possible improved outcomes were seen due to BES promot-</span></p>
<p style="top:260.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ing spontaneous recovery of injured nerves following HNC </span></p>
<p style="top:272.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">resection; however, additional trials are needed to confirm </span></p>
<p style="top:284.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">this. This study reveals the potential of BES to preserve </span></p>
<p style="top:296.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">shoulder function after oncologic neck dissection.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">40</span></sup></p>
<p style="top:308.2pt;left:330.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">However, the role of BES in oncology continues to be </span></p>
<p style="top:320.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">highly debated and variable, further validation studies are </span></p>
<p style="top:332.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">required to fully understand the role of BES in patient man-</span></p>
<p style="top:344.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">agement (Table 1). Additional multicenter, randomized, </span></p>
<p style="top:356.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">double-blinded studies involving BES for a variety of can-</span></p>
<p style="top:368.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">cer subtypes is required to fully demonstrate the efficacy of </span></p>
<p style="top:380.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">BES in oncological patient management.</span></p>
<p style="top:408.6pt;left:318.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Future Studies</span></b></p>
<p style="top:428.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">The therapeutic potential of ES to enhance peripheral nerve </span></p>
<p style="top:440.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">repair is evident, but additional clinical trials are necessary </span></p>
<p style="top:452.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">to validate possible benefits. A single-dose BES of periph-</span></p>
<p style="top:464.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">eral nerve proximal to the repair site has shown to accelerate </span></p>
<p style="top:476.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">and improve functional regeneration. Although reports have </span></p>
<p style="top:488.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">been positive, a serious limitation of previous studies has </span></p>
<p style="top:500.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">been confinement of therapy application to the intraopera-</span></p>
<p style="top:512.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tive period. In response, a wireless, bioresorbable electrical </span></p>
<p style="top:524.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">peripheral nerve stimulator has been introduced.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">3</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> This pro-</span></p>
<p style="top:536.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">grammable platform allows ES of injured nerves to extend </span></p>
<p style="top:548.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">beyond the intraoperative period. Data reveal that chronic </span></p>
<p style="top:560.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ES at 20 Hz for 1 hour per day for 6 days after rat sciatic </span></p>
<p style="top:572.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">nerve transection repair achieved significantly greater func-</span></p>
<p style="top:584.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tional recovery than those treated with BES. Although these </span></p>
<p style="top:596.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">results conflict with prior studies, which demonstrated that </span></p>
<p style="top:608.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">multiple periods of ES demonstrated no benefit, similar clin-</span></p>
<p style="top:620.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ical studies have not been performed and future prospective </span></p>
<p style="top:632.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">trials are required to fully understand the efficacy of multiple </span></p>
<p style="top:644.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ES periods on improving nerve growth. Thus, the use of </span></p>
<p style="top:656.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">wireless bioresorbable electronics opens new doors to apply-</span></p>
<p style="top:668.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ing ES for peripheral nerve regeneration.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">3</span></sup></p>
<p style="top:680.2pt;left:330.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">In contrast to BES, long-term peripheral nerve stimula-</span></p>
<p style="top:692.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion (PNS) has been shown to drastically improve patient </span></p>
<p style="top:704.2pt;left:318.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">outcomes in those experiencing painful nerve injuries. A </span></p>
<p style="top:67.9pt;left:63.0pt;line-height:9.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Table 1.</span></b><span style="font-family:GillSansMTPro,serif;font-size:9.0pt"> Comparative Functional Outcomes of 3 Clinical Trials Using Brief Intraoperative Electrical Stimulation (BES) at 20 Hz for 1 </span></p>
<p style="top:78.4pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Hour Immediately Following Standard Procedure.</span><sup><span style="font-family:GillSansMTPro,serif;font-size:5.8pt">7,32,37</span></sup></p>
<p style="top:96.9pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Summarized BES clinical studies</span></p>
<p style="top:115.4pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Surgical procedure</span></p>
<p style="top:115.4pt;left:203.9pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Target nerve</span></p>
<p style="top:115.4pt;left:282.1pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Nerve type</span></p>
<p style="top:115.4pt;left:347.9pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Functional outcomes in BES-treated vs untreated groups</span></p>
<p style="top:133.2pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Carpal tunnel release</span></p>
<p style="top:133.2pt;left:196.7pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Median</span></p>
<p style="top:133.2pt;left:266.3pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Motor and sensory</span></p>
<p style="top:133.2pt;left:347.5pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">No significant increase</span></p>
<p style="top:144.7pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Epineural nerve repair</span></p>
<p style="top:144.7pt;left:196.7pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Digital</span></p>
<p style="top:144.7pt;left:266.3pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Sensory</span></p>
<p style="top:144.7pt;left:347.5pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Significantly increased digit temperature distinction, </span></p>
<p style="top:155.2pt;left:353.5pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">pressure detection, and spatial discrimination</span></p>
<p style="top:166.7pt;left:63.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Level II </span><span style="font-family:MathematicalPiLTStd,serif;font-size:9.0pt">&#xb1;</span><span style="font-family:GillSansMTPro,serif;font-size:9.0pt"> level IV oncologic neck </span></p>
<p style="top:177.2pt;left:69.0pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">dissection</span></p>
<p style="top:166.7pt;left:196.7pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Spinal accessory</span></p>
<p style="top:166.7pt;left:266.4pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Motor</span></p>
<p style="top:166.7pt;left:347.5pt;line-height:9.0pt"><span style="font-family:GillSansMTPro,serif;font-size:9.0pt">Significantly increased preservation of shoulder function</span></p>


<p style="top:40.8pt;left:48.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">984 </span></p>
<p style="top:40.8pt;left:365.8pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Neurorehabilitation and Neural Repair 34(11)</span></i></p>
<p style="top:67.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">2004 study conducted by Eisenberg et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">41</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> demonstrated </span></p>
<p style="top:79.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">that up to 78% of patients treated with long-term PNS fol-</span></p>
<p style="top:91.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">lowing nerve injury may report pain relief with 3- to 16-year </span></p>
<p style="top:103.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">follow-up. Contemporary studies continue to support the </span></p>
<p style="top:115.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">findings of the aforementioned study, and a 2015 study con-</span></p>
<p style="top:127.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">ducted by Lee et al</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">42</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> found that long-term PNS may reduce </span></p>
<p style="top:139.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">pain scores in patients with chronic intractable headaches </span></p>
<p style="top:151.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">by more than one-third.</span></p>
<p style="top:163.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Furthermore, noninvasive ES, such as transcutaneous </span></p>
<p style="top:175.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">electrical nerve stimulation (TENS), have gained popularity </span></p>
<p style="top:187.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">over the past decade in treating neuropathic pain. TENS is </span></p>
<p style="top:199.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">often administered at high intensities close to the site of </span></p>
<p style="top:211.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">pain with hopes of achieving pain relief.</span><sup><span style="font-family:Times New Roman,serif;font-size:6.5pt">43</span></sup><span style="font-family:Times New Roman,serif;font-size:10.0pt"> However, studies </span></p>
<p style="top:223.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">evaluating the efficacy of TENS are few and lack the power </span></p>
<p style="top:235.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">necessary to fully establish this technique as a route for </span></p>
<p style="top:247.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">management of chronic pain.</span></p>
<p style="top:259.9pt;left:60.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">Last, as BES studies translate from animal experiments </span></p>
<p style="top:271.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">to human experimentation, several limitations may become </span></p>
<p style="top:283.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">clear. First, the difference in nerve length and diameter </span></p>
<p style="top:295.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">between the rats/mice and humans may present difficulties </span></p>
<p style="top:307.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">in translation and require additional experimentation to </span></p>
<p style="top:319.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">locate the optimum site for ES. Furthermore, stimulation at </span></p>
<p style="top:331.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">20-Hz for 1 hour may be suboptimal for human subjects, </span></p>
<p style="top:343.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">requiring prospective research.</span></p>
<p style="top:372.3pt;left:48.0pt;line-height:12.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:12.0pt">Conclusions</span></b></p>
<p style="top:391.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">In laboratory animals and humans, ES has been repeat-</span></p>
<p style="top:403.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">edly shown to accelerate the regeneration of injured </span></p>
<p style="top:415.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">axons and reinnervation of target tissues. Several clinical </span></p>
<p style="top:427.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">trials performed have yielded encouraging results that </span></p>
<p style="top:439.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">place BES as a candidate adjunctive therapy, but more </span></p>
<p style="top:451.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">data are necessary to determine application frequency for </span></p>
<p style="top:463.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">optimum effectiveness. Additional human studies are </span></p>
<p style="top:475.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">needed to properly assess recovery of thenar motor func-</span></p>
<p style="top:487.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">tion after CTRS and potency of ES after delayed repair. </span></p>
<p style="top:499.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">The true capacity of ES to help overcome limitations in </span></p>
<p style="top:511.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">peripheral nerve regeneration remains promising and to </span></p>
<p style="top:523.9pt;left:48.0pt;line-height:10.0pt"><span style="font-family:Times New Roman,serif;font-size:10.0pt">be uncovered.</span></p>
<p style="top:547.9pt;left:48.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Declaration of Conflicting Interests</span></b></p>
<p style="top:563.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">The author(s) declared no potential conflicts of interest with </span></p>
<p style="top:574.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">respect to the research, authorship, and/or publication of this </span></p>
<p style="top:585.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">article.</span></p>
<p style="top:608.9pt;left:48.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Funding</span></b></p>
<p style="top:624.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">The author(s) disclosed receipt of the following financial support </span></p>
<p style="top:635.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">for the research, authorship, and/or publication of this article: RS </span></p>
<p style="top:646.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">is funded in part by an MSTP Grant from the National Institutes of </span></p>
<p style="top:657.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Health (T32-GM08620).</span></p>
<p style="top:680.9pt;left:48.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">ORCID iDs</span></b></p>
<p style="top:696.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Seth C. Ransom </span></p>
<p style="top:696.7pt;left:120.5pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> https://orcid.org/0000-0001-5949-1703</span></p>
<p style="top:710.7pt;left:48.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Brian Hanst </span></p>
<p style="top:710.7pt;left:105.5pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> https://orcid.org/0000-0002-0433-2542</span></p>
<p style="top:67.8pt;left:303.0pt;line-height:10.0pt"><b><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">References</span></b></p>
<p style="top:83.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 1. Grinsell D, Keating CP. Peripheral nerve reconstruction </span></p>
<p style="top:94.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">after injury: a review of clinical and experimental therapies. </span></p>
<p style="top:105.6pt;left:319.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Biomed Res Int</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2014;2014:698256.</span></p>
<p style="top:116.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 2. Kouyoumdjian JA. Peripheral nerve injuries: a retrospective </span></p>
<p style="top:127.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">survey of 456 cases. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Muscle Nerve</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2006;34:785-788.</span></p>
<p style="top:138.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 3. Koo J, MacEwan MR, Kang SK, et al. Wireless bioresorb-</span></p>
<p style="top:149.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">able electronic system enables sustained nonpharmacological </span></p>
<p style="top:160.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">neuroregenerative therapy. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Nat Med</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2018;24:1830-1836.</span></p>
<p style="top:171.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 4. Scheib J, Hoke A. Advances in peripheral nerve regeneration. </span></p>
<p style="top:182.6pt;left:319.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Nat Rev Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2013;9:668-676.</span></p>
<p style="top:193.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 5. Ruijs AC, Jaquet JB, Kalmijn S, Giele H, Hovius SER. </span></p>
<p style="top:204.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Median and ulnar nerve injuries: a meta-analysis of predictors </span></p>
<p style="top:215.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">of motor and sensory recovery after modern microsurgical </span></p>
<p style="top:226.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">nerve repair. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Plast Reconstr Surg</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2005;116:484-494.</span></p>
<p style="top:237.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 6. Spinner RJ, Hanna AS, Maldonado AA, Wilson TJ. Peripheral </span></p>
<p style="top:248.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">nerve. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Oper Neurosurg (Hagerstown)</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2019;17(suppl </span></p>
<p style="top:259.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2):S229-S255.</span></p>
<p style="top:270.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 7. Gordon T, Tyreman N, Raji MA. The basis for diminished </span></p>
<p style="top:281.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">functional recovery after delayed peripheral nerve repair. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J </span></i></p>
<p style="top:292.6pt;left:319.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2011;31:5325-5334.</span></p>
<p style="top:303.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 8. Seddon HJ. Three types of nerve injury. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Brain</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 1943;66: </span></p>
<p style="top:314.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">237-288.</span></p>
<p style="top:325.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 9. Sunderland SS, Williams HB. Nerve injuries and their repair: </span></p>
<p style="top:336.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">a critical appraisal. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Plast Reconstr Surg</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 1992;89(6):1170.</span></p>
<p style="top:347.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 10. Houdek MT, Shin AY. Management and complications of </span></p>
<p style="top:358.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">traumatic peripheral nerve injuries. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Hand Clin</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2015;31: </span></p>
<p style="top:369.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">151-163.</span></p>
<p style="top:380.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 11. Spinner RJ, Shin AY, Bishop AT. Advances in the repair </span></p>
<p style="top:391.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">of peripheral nerve injury. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosurgery</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2015;62(suppl 1): </span></p>
<p style="top:402.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">146-151.</span></p>
<p style="top:413.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 12. Gunter C, Delbeke J, Ortiz-Catalan M. Safety of long-term </span></p>
<p style="top:424.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">electrical peripheral nerve stimulation: review of the state of </span></p>
<p style="top:435.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">the art. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Neuroeng Rehabil</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2019;16:13.</span></p>
<p style="top:446.6pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 13. Reddy CG, Flouty OE, Holland MT, Rettenmaier LA, Zanaty </span></p>
<p style="top:457.6pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">M, Elahi F. Novel technique for trialing peripheral nerve stim-</span></p>
<p style="top:468.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">ulation: ultrasonography-guided StimuCath trial. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosurg </span></i></p>
<p style="top:479.5pt;left:319.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Focus</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2017;42:E5.</span></p>
<p style="top:490.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 14. Schiefer M, Tan D, Sidek SM, Tyler DJ. Sensory feedback </span></p>
<p style="top:501.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">by peripheral nerve stimulation improves task performance in </span></p>
<p style="top:512.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">individuals with upper limb loss using a myoelectric prosthe-</span></p>
<p style="top:523.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">sis. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Neural Eng</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2016;13:016001.</span></p>
<p style="top:534.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 15. Nix WA, Hopf HC. Electrical stimulation of regenerat-</span></p>
<p style="top:545.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">ing nerve and its effect on motor recovery. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Brain Res</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:556.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">1983;272:21-25.</span></p>
<p style="top:567.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 16. Pockett S, Gavin RM. Acceleration of peripheral nerve </span></p>
<p style="top:578.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">regeneration after crush injury in rat. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosci Lett</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 1985;59: </span></p>
<p style="top:589.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">221-224.</span></p>
<p style="top:600.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 17. Al-Majed AA, Neumann CM, Brushart TM, Gordon T. Brief </span></p>
<p style="top:611.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">electrical stimulation promotes the speed and accuracy of </span></p>
<p style="top:622.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">motor axonal regeneration. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2000;20:2602-2608.</span></p>
<p style="top:633.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 18. Brushart TM, Hoffman PN, Royall RM, Murinson BB, Witzel </span></p>
<p style="top:644.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">C, Gordon T. Electrical stimulation promotes motoneuron </span></p>
<p style="top:655.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">regeneration without increasing its speed or conditioning the </span></p>
<p style="top:666.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">neuron. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2002;22:6631-6638.</span></p>
<p style="top:677.5pt;left:303.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 19. Al-Majed AA, Brushart TM, Gordon T. Electrical stimu-</span></p>
<p style="top:688.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">lation accelerates and increases expression of BDNF and </span></p>
<p style="top:699.5pt;left:319.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">trkB mRNA in regenerating rat femoral motoneurons. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Eur J </span></i></p>
<p style="top:710.5pt;left:319.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2000;12:4381-4390.</span></p>


<p style="top:40.8pt;left:63.0pt;line-height:10.0pt"><i><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">Ransom et al </span></i></p>
<p style="top:40.8pt;left:540.0pt;line-height:10.0pt"><span style="font-family:GillSansMTPro,serif;font-size:10.0pt">985</span></p>
<p style="top:68.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 20. Gordon T, Udina E, Verge VMK, de Chaves EIP. Brief </span></p>
<p style="top:79.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">electrical stimulation accelerates axon regeneration in the </span></p>
<p style="top:90.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">peripheral nervous system and promotes sensory axon regen-</span></p>
<p style="top:101.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">eration in the central nervous system. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Motor Control</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2009;13: </span></p>
<p style="top:112.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">412-441.</span></p>
<p style="top:123.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 21. Brushart TM, Jari R, Verge V, Rohde C, Gordon T. Electrical </span></p>
<p style="top:134.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">stimulation restores the specificity of sensory axon regenera-</span></p>
<p style="top:145.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">tion. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Exp Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2005;194:221-229.</span></p>
<p style="top:156.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 22. Geremia NM, Gordon T, Brushart TM, Al-Majed AA, Verge </span></p>
<p style="top:167.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">VM. Electrical stimulation promotes sensory neuron regen-</span></p>
<p style="top:178.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">eration and growth-associated gene expression. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Exp Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:189.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2007;205:347-359.</span></p>
<p style="top:200.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 23. Gordon T, English AW. Strategies to promote peripheral </span></p>
<p style="top:211.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">nerve regeneration: electrical stimulation and/or exercise. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Eur </span></i></p>
<p style="top:222.0pt;left:79.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2016;43:336-350.</span></p>
<p style="top:233.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 24. Al-Majed AA, Tam SL, Gordon T. Electrical stimulation </span></p>
<p style="top:244.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">accelerates and enhances expression of regeneration-associ-</span></p>
<p style="top:255.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">ated genes in regenerating rat femoral motoneurons. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Cell Mol </span></i></p>
<p style="top:266.0pt;left:79.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurobiol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2004;24:379-402.</span></p>
<p style="top:277.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 25. English AW, Schwartz G, Meador W, Sabatier MJ, Mulligan </span></p>
<p style="top:288.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">A. Electrical stimulation promotes peripheral axon regen-</span></p>
<p style="top:299.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">eration by enhanced neuronal neurotrophin signaling. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Dev </span></i></p>
<p style="top:310.0pt;left:79.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurobiol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2007;67:158-172.</span></p>
<p style="top:321.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 26. Menorca RM, Fussell TS, Elfar JC. Nerve physiology: mech-</span></p>
<p style="top:332.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">anisms of injury and recovery. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Hand Clin</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2013;29:317-330.</span></p>
<p style="top:343.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 27. Huang J, Zhang Y, Lu L, Hu X, Luo Z. Electrical stimula-</span></p>
<p style="top:354.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">tion accelerates nerve regeneration and functional recovery </span></p>
<p style="top:365.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">in delayed peripheral nerve injury in rats. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Eur J Neurosci</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:376.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2013;38:3691-3701.</span></p>
<p style="top:387.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 28. Elzinga K, Tyreman N, Ladak A, Savaryn B, Olson J, Gordon </span></p>
<p style="top:398.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">T. Brief electrical stimulation improves nerve regeneration </span></p>
<p style="top:409.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">after delayed repair in Sprague Dawley rats. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Exp Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:420.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2015;269:142-153.</span></p>
<p style="top:431.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 29. Leit ME, Weiser RW, Tomaino MM. Patient-reported out-</span></p>
<p style="top:442.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">come after carpal tunnel release for advanced disease: a pro-</span></p>
<p style="top:453.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">spective and longitudinal assessment in patients older than </span></p>
<p style="top:464.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">age 70. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Hand Surg Am</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2004;29:379-383.</span></p>
<p style="top:475.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 30. Urits I, Gress K, Charipova K, Orhurhu V, Kaye AD, </span></p>
<p style="top:486.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Viswanath O. Recent advances in the understanding and man-</span></p>
<p style="top:497.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">agement of carpal tunnel syndrome: a comprehensive review. </span></p>
<p style="top:508.0pt;left:79.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Curr Pain Headache Rep</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2019;23:70.</span></p>
<p style="top:519.0pt;left:63.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 31. Gordon T, Brushart TM, Amirjani N, Chan KM. The poten-</span></p>
<p style="top:530.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">tial of electrical stimulation to promote functional recovery </span></p>
<p style="top:541.0pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">after peripheral nerve injury&#x2014;comparisons between rats and </span></p>
<p style="top:551.9pt;left:79.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">humans. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Acta Neurochir Suppl</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2007;100:3-11.</span></p>
<p style="top:67.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 32. Gordon T, Amirjani N, Edwards DC, Chan KM. Brief post-</span></p>
<p style="top:78.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">surgical electrical stimulation accelerates axon regeneration </span></p>
<p style="top:89.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">and muscle reinnervation without affecting the functional </span></p>
<p style="top:100.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">measures in carpal tunnel syndrome patients. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Exp Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:111.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2010;223:192-202.</span></p>
<p style="top:122.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 33. Chan KM, Curran MWT, Gordon T. The use of brief post-</span></p>
<p style="top:133.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">surgical low frequency electrical stimulation to enhance </span></p>
<p style="top:144.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">nerve regeneration in clinical practice. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Physiol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2016;594: </span></p>
<p style="top:155.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">3553-3559.</span></p>
<p style="top:166.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 34. Power HA, Morhart MJ, Olson JL, Chan KM. Postsurgical </span></p>
<p style="top:177.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">electrical stimulation enhances recovery following surgery </span></p>
<p style="top:188.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">for severe cubital tunnel syndrome: a double-blind random-</span></p>
<p style="top:199.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">ized controlled trial. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosurgery</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2020;86:769-777.</span></p>
<p style="top:210.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 35. Wong JN, Olson JL, Morhart MJ, Chan KM. Electrical stimu-</span></p>
<p style="top:221.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">lation enhances sensory recovery: a randomized controlled </span></p>
<p style="top:232.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">trial. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Ann Neurol</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2015;77:996-1006.</span></p>
<p style="top:243.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 36. Shapira Y, Sammons V, Forden J, et al. Brief electrical stimu-</span></p>
<p style="top:254.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">lation promotes nerve regeneration following experimental </span></p>
<p style="top:265.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">in-continuity nerve injury. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neurosurgery</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2019;85:156-163.</span></p>
<p style="top:276.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 37. Celik B, Coskun H, Kumas FF, et al. Accessory nerve func-</span></p>
<p style="top:287.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">tion after level 2b-preserving selective neck dissection. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Head </span></i></p>
<p style="top:298.9pt;left:334.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Neck</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2009;31:1496-1501.</span></p>
<p style="top:309.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 38. van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, </span></p>
<p style="top:320.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Roodenburg JL. Shoulder complaints after nerve sparing neck </span></p>
<p style="top:331.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">dissections. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Int J Oral Maxillofac Surg</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2004;33:253-257.</span></p>
<p style="top:342.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 39. Chepeha DB, Taylor RJ, Chepeha JC, et al. Functional </span></p>
<p style="top:353.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">assessment using Constant&#x2019;s Shoulder Scale after modi-</span></p>
<p style="top:364.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">fied radical and selective neck dissection. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Head Neck</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:375.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2002;24:432-436.</span></p>
<p style="top:386.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 40. Barber B, Seikaly H, Chan KM, et al. Intraoperative Brief </span></p>
<p style="top:397.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">Electrical Stimulation of the Spinal Accessory Nerve (BEST </span></p>
<p style="top:408.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">SPIN) for prevention of shoulder dysfunction after oncologic </span></p>
<p style="top:419.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">neck dissection: a double-blinded, randomized controlled </span></p>
<p style="top:430.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">trial. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">J Otolaryngol Head Neck Surg</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2018;47:7.</span></p>
<p style="top:441.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 41. Eisenberg E, Waisbrod H, Gerbershagen HU. Long-term </span></p>
<p style="top:452.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">peripheral nerve stimulation for painful nerve injuries. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Clin J </span></i></p>
<p style="top:463.9pt;left:334.0pt;line-height:9.0pt"><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Pain</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2004;20:143-146.</span></p>
<p style="top:474.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 42. Lee PB, Horazeck C, Nahm FS, Huh BK. Peripheral nerve </span></p>
<p style="top:485.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">stimulation for the treatment of chronic intractable head-</span></p>
<p style="top:496.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">aches: long-term efficacy and safety study. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Pain Physician</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. </span></p>
<p style="top:507.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">2015;18:505-516.</span></p>
<p style="top:518.9pt;left:318.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt"> 43. Johnson MI, Bjordal JM. Transcutaneous electrical nerve </span></p>
<p style="top:529.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">stimulation for the management of painful conditions: </span></p>
<p style="top:540.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">focus on neuropathic pain. </span><i><span style="font-family:Times New Roman,serif;font-size:9.0pt">Expert Rev Neurother</span></i><span style="font-family:Times New Roman,serif;font-size:9.0pt">. 2011;11: </span></p>
<p style="top:552.9pt;left:334.0pt;line-height:9.0pt"><span style="font-family:Times New Roman,serif;font-size:9.0pt">735-753.</span></p>

</div>
